Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease. The company was founded by Brian Taylor Slingsby on May 31, 2019 and is headquartered in Radnor, PA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Rodman David Malcom | Chief Medical Officer | Sep 12 '24 | Option Exercise | 1.08 | 6,349 | 6,857 | 125,605 | Sep 12 04:32 PM | Rodman David Malcom | Chief Medical Officer | Sep 11 '24 | Option Exercise | 0.54 | 5,018 | 2,710 | 119,256 | Sep 12 04:32 PM | Rodman David Malcom | Chief Medical Officer | Aug 12 '24 | Option Exercise | 0.84 | 11,365 | 9,565 | 114,238 | Aug 13 04:20 PM | Slingsby Brian Taylor | Director | Jul 24 '24 | Sale | 13.05 | 550,000 | 7,177,500 | 8,644,579 | Jul 26 09:45 PM | Rodman David Malcom | Chief Medical Officer | Jul 16 '24 | Option Exercise | 1.08 | 525 | 567 | 103,398 | Jul 18 06:34 PM | Rodman David Malcom | Chief Medical Officer | Jul 16 '24 | Sale | 15.00 | 525 | 7,876 | 102,873 | Jul 18 06:34 PM | Rodman David Malcom | Chief Medical Officer | Jul 12 '24 | Option Exercise | 1.08 | 6,349 | 6,857 | 102,873 | Jul 12 04:39 PM | Rodman David Malcom | Chief Medical Officer | Jul 11 '24 | Option Exercise | 0.54 | 5,017 | 2,709 | 96,524 | Jul 12 04:39 PM | Levy Adam Scott | CFO and Secretary | Jul 11 '24 | Sale | 13.14 | 10,757 | 141,394 | 247,611 | Jul 12 04:37 PM | Congleton Jon | Chief Executive Officer | Jul 11 '24 | Sale | 13.34 | 15,746 | 210,075 | 911,212 | Jul 12 04:36 PM | Congleton Jon | Chief Executive Officer | Jun 17 '24 | Sale | 12.25 | 17,766 | 217,712 | 958,505 | Jun 20 05:44 PM | Congleton Jon | Chief Executive Officer | Jun 18 '24 | Sale | 11.99 | 16,607 | 199,073 | 941,898 | Jun 20 05:44 PM | Congleton Jon | Chief Executive Officer | Jun 20 '24 | Sale | 11.73 | 14,940 | 175,237 | 926,958 | Jun 20 05:44 PM | Congleton Jon | Chief Executive Officer | Jun 13 '24 | Sale | 12.74 | 39,961 | 509,027 | 992,500 | Jun 14 06:15 PM | Congleton Jon | Chief Executive Officer | Jun 12 '24 | Sale | 12.77 | 16,607 | 212,013 | 1,032,461 | Jun 14 06:15 PM | Congleton Jon | Chief Executive Officer | Jun 14 '24 | Sale | 12.52 | 16,229 | 203,163 | 976,271 | Jun 14 06:15 PM | Levy Adam Scott | CFO and Secretary | Jun 11 '24 | Sale | 12.94 | 96,815 | 1,252,718 | 255,462 | Jun 13 05:33 PM | Rodman David Malcom | Chief Medical Officer | Jun 12 '24 | Option Exercise | 1.08 | 6,349 | 6,857 | 89,729 | Jun 13 05:32 PM | Rodman David Malcom | Chief Medical Officer | Jun 11 '24 | Option Exercise | 0.54 | 5,017 | 2,709 | 83,380 | Jun 13 05:32 PM | Rodman David Malcom | Chief Medical Officer | May 13 '24 | Option Exercise | 0.84 | 11,366 | 9,566 | 78,363 | May 15 04:43 PM | Rodman David Malcom | Chief Medical Officer | May 09 '24 | Option Exercise | 1.08 | 100 | 108 | 67,097 | May 10 04:17 PM | Rodman David Malcom | Chief Medical Officer | May 09 '24 | Sale | 15.00 | 100 | 1,500 | 66,997 | May 10 04:17 PM | Rodman David Malcom | Chief Medical Officer | Apr 12 '24 | Option Exercise | 1.08 | 6,349 | 6,857 | 66,997 | Apr 15 04:24 PM | Rodman David Malcom | Chief Medical Officer | Apr 11 '24 | Option Exercise | 0.54 | 5,017 | 2,709 | 60,648 | Apr 15 04:24 PM | Rodman David Malcom | Chief Medical Officer | Mar 12 '24 | Option Exercise | 1.08 | 6,348 | 6,856 | 55,631 | Mar 13 05:35 PM | Rodman David Malcom | Chief Medical Officer | Mar 11 '24 | Option Exercise | 0.54 | 5,017 | 2,709 | 49,283 | Mar 13 05:35 PM | Samsara BioCapital GP, LLC | 10% Owner | Feb 12 '24 | Buy | 13.50 | 555,555 | 7,499,992 | 5,074,916 | Feb 14 09:06 PM | Rodman David Malcom | Chief Medical Officer | Feb 12 '24 | Option Exercise | 0.84 | 11,366 | 9,566 | 44,266 | Feb 13 04:08 PM | Rodman David Malcom | Chief Medical Officer | Jan 12 '24 | Option Exercise | 1.08 | 6,348 | 6,856 | 32,900 | Jan 12 04:01 PM | Rodman David Malcom | Chief Medical Officer | Jan 11 '24 | Option Exercise | 0.54 | 5,017 | 2,709 | 26,552 | Jan 12 04:01 PM | Rodman David Malcom | Chief Medical Officer | Dec 11 '23 | Option Exercise | 0.54 | 5,018 | 2,710 | 20,069 | Dec 12 05:08 PM | Congleton Jon | Chief Executive Officer | Nov 22 '23 | Buy | 5.97 | 4,250 | 25,356 | 1,049,068 | Nov 27 04:01 PM | Rodman David Malcom | Chief Medical Officer | Nov 13 '23 | Option Exercise | 0.54 | 5,017 | 2,709 | 15,051 | Nov 14 06:18 PM | Rodman David Malcom | Chief Medical Officer | Nov 03 '23 | Option Exercise | 0.54 | 10,034 | 5,418 | 10,034 | Nov 07 05:15 PM |
|